Keyphrases
Multisystem Inflammatory Syndrome in children (MIS-C)
100%
COVID-19
46%
Disease Registry
33%
Hospital Evaluation
33%
Children with Congenital Heart Disease
33%
Anatomic
33%
Children's Survey
33%
Screening Guidelines
33%
Pericardiocentesis
33%
Kawasaki Disease
33%
Hospital Management
33%
Von Willebrand Factor Antigen
33%
Developmental Screening
33%
Surgical Repair
33%
Vascular Ring
33%
Vascular Sling
33%
Subxiphoid Approach
28%
Acute Phase Reactants
20%
Left Subclavian Artery
20%
Right Aortic Arch
20%
Polymerase Chain Reaction
14%
Serology
14%
Clinical Features
14%
Subxiphoid
14%
Effusion
14%
Clinical Outcomes
14%
Factor VIII Level
13%
Cardiac Dysfunction
13%
Endothelial Dysfunction
13%
Pulmonary Artery Sling
13%
Kommerell's Diverticulum
13%
Primary Care Providers
12%
American Heart Association Guidelines
12%
Severe Cases
11%
Aspirin
10%
Procedure Time
9%
Complication Rate
9%
Single Center
9%
Echocardiography Guided
9%
SARS-CoV-2 Infection
9%
Congenital Heart Disease
8%
Family Physicians
8%
Neurodevelopmental Screening
8%
Pediatricians
8%
Pediatric Primary Care
8%
Hospital Protocol
7%
C-factor
6%
Ligamentum Arteriosum
6%
Asymptomatic children
6%
Chylothorax
6%
Medicine and Dentistry
Serositis
100%
Developmental Screening
33%
Blood Clotting Factor 8
33%
Von Willebrand Factor
33%
Persistent Truncus Arteriosus
33%
Pericardiocentesis
33%
Kawasaki Disease
33%
Vascular Ring
33%
COVID-19
33%
Infection
27%
Aortic Arch
23%
Acute Phase Protein
20%
Diseases
20%
Pediatrics
19%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Left Subclavian Artery
14%
Effusion
14%
Clinical Feature
14%
Polymerase Chain Reaction
14%
Endothelial Dysfunction
13%
Coronavirinae
13%
Acetylsalicylic Acid
12%
Primary Health Care
10%
Diverticulum
9%
Recurrent Disease
9%
Pulmonary Artery Sling
9%
Coronary Artery
9%
Echocardiography
9%
Coagulopathy
6%
D-Dimer
6%
Awareness
6%
Outpatient
6%
Patient Referral
6%
Thromboprophylaxis
6%
Pathophysiology
6%
Pediatrician
6%
Anti-Inflammatory Drug
6%
Cardiology
5%
Anakinra
5%
Low Molecular Weight Heparin
5%
Heparin
5%
Cross Sectional Study
5%
Immunoglobulin
5%
Hypertensive Factor
5%
